Skip to content

HyCON Labs

+1 (631) 210-5235

info@hyconlabs.com

  • Services
    • Product Development
      • Formulation
        • Preformulation Studies
        • Formulation Development
      • Analytical
        • Analytical Method Development
        • Analytical Testing
        • Stability Testing
      • Polymorph Screening
      • IND Enabling Studies
      • GLP Toxicology Studies
      • Therapeutic Area
        • Orphan Disease / Rare Disease
        • Oncology
        • CNS / Neurology
        • Cardiometabolic Diseases
      • Pediatrics
    • Processing Technologies
      • Spray Drying
      • Wurster Fluid Bed Coating
      • Hot Melt Extrusion
      • Micronization & Milling
      • Particle Engineering
    • Clinical Trial Supply
      • Clinical Manufacturing
      • Solutions by Phase
        • Preclinical Manufacturing
        • Phase 1 Clinical Manufacturing
        • Phase 2 Clinical Manufacturing
        • Phase 3 Clinical Manufacturing
      • Comparator Sourcing
      • Direct-to-Patient Services
      • Clinical Returns
      • Clinical Packaging
      • Project & Supply Management
    • Pharmaceutical Manufacturing
      • Commercial Manufacturing
      • over-the-counter-contract-manufacturing
      • Technology Transfers
      • High Potent API (HPAPI)
      • Scheduled Substances
      • Packaging
      • Regulatory Services
  • Dosage Forms
    • Oral Dosage
      • Oral Solid Dosage
      • Tablets
      • Capsules
      • Softgel
      • Oral Films
      • Oral Suspension & Solutions
      • Semi-Solids
      • Powders & Granules
    • Injectables / Parenterals
    • Topical
      • Semi Solids Dosage Forms
      • Transdermal Patches
      • Ophthalmic / Ocular
    • Transdermal
      • Semi Solids Dosage Forms
      • Transdermal Patches
    • Ophthalmic / Ocular
    • Inhalables / Nasal
    • Liquids
  • Formulation Technologies
    • Bioavailability Enhancement
    • Lipid Nanoparticles
      • Nanostructured Lipid Carriers
      • Liposomes
      • Solid Lipid Nanoparticles
      • Self-Emulsifying Drug Delivery Systems
      • Nanoemulsions
    • Lipid-Based Drug Delivery
    • Nanoparticles
      • Polymeric Nanoparticles
      • Nanocrystals
    • Amorphous Solid Dispersions
    • Controlled Release
    • Sustained Release
    • Microencapsulation
    • Multiparticulate
    • Taste Masking
    • Orally Disintegrating Tablets
    • Abuse Deterrent
  • Resources
    • Articles
    • Case Study
    • E-Book
    • Executive Summary
    • Offering Sheet
    • White Paper
  • About
    • Schedule a Meeting
    • Corporate Responsibility
    • Contact Us
Contact Us
hyconlabs-final-logo-3 (1) (1)
  • Services
    • Product Development
      • Formulation
        • Preformulation Studies
        • Formulation Development
      • Analytical
        • Analytical Method Development
        • Analytical Testing
        • Stability Testing
      • Polymorph Screening
      • IND Enabling Studies
      • GLP Toxicology Studies
      • Therapeutic Area
        • Orphan Disease / Rare Disease
        • Oncology
        • CNS / Neurology
        • Cardiometabolic Diseases
      • Pediatrics
    • Processing Technologies
      • Spray Drying
      • Wurster Fluid Bed Coating
      • Hot Melt Extrusion
      • Micronization & Milling
      • Particle Engineering
    • Clinical Trial Supply
      • Clinical Manufacturing
      • Solutions by Phase
        • Preclinical Manufacturing
        • Phase 1 Clinical Manufacturing
        • Phase 2 Clinical Manufacturing
        • Phase 3 Clinical Manufacturing
      • Comparator Sourcing
      • Direct-to-Patient Services
      • Clinical Returns
      • Clinical Packaging
      • Project & Supply Management
    • Pharmaceutical Manufacturing
      • Commercial Manufacturing
      • over-the-counter-contract-manufacturing
      • Technology Transfers
      • High Potent API (HPAPI)
      • Scheduled Substances
      • Packaging
      • Regulatory Services
  • Dosage Forms
    • Oral Dosage
      • Oral Solid Dosage
      • Tablets
      • Capsules
      • Softgel
      • Oral Films
      • Oral Suspension & Solutions
      • Semi-Solids
      • Powders & Granules
    • Injectables / Parenterals
    • Topical
      • Semi Solids Dosage Forms
      • Transdermal Patches
      • Ophthalmic / Ocular
    • Transdermal
      • Semi Solids Dosage Forms
      • Transdermal Patches
    • Ophthalmic / Ocular
    • Inhalables / Nasal
    • Liquids
  • Formulation Technologies
    • Bioavailability Enhancement
    • Lipid Nanoparticles
      • Nanostructured Lipid Carriers
      • Liposomes
      • Solid Lipid Nanoparticles
      • Self-Emulsifying Drug Delivery Systems
      • Nanoemulsions
    • Lipid-Based Drug Delivery
    • Nanoparticles
      • Polymeric Nanoparticles
      • Nanocrystals
    • Amorphous Solid Dispersions
    • Controlled Release
    • Sustained Release
    • Microencapsulation
    • Multiparticulate
    • Taste Masking
    • Orally Disintegrating Tablets
    • Abuse Deterrent
  • Resources
    • Articles
    • Case Study
    • E-Book
    • Executive Summary
    • Offering Sheet
    • White Paper
  • About
    • Schedule a Meeting
    • Corporate Responsibility
    • Contact Us
Contact Us
hyconlabs-final-logo-3 (1) (1)
  • Services
    • Product Development
      • Formulation
        • Preformulation Studies
        • Formulation Development
      • Analytical
        • Analytical Method Development
        • Analytical Testing
        • Stability Testing
      • Polymorph Screening
      • IND Enabling Studies
      • GLP Toxicology Studies
      • Therapeutic Area
        • Orphan Disease / Rare Disease
        • Oncology
        • CNS / Neurology
        • Cardiometabolic Diseases
      • Pediatrics
    • Processing Technologies
      • Spray Drying
      • Wurster Fluid Bed Coating
      • Hot Melt Extrusion
      • Micronization & Milling
      • Particle Engineering
    • Clinical Trial Supply
      • Clinical Manufacturing
      • Solutions by Phase
        • Preclinical Manufacturing
        • Phase 1 Clinical Manufacturing
        • Phase 2 Clinical Manufacturing
        • Phase 3 Clinical Manufacturing
      • Comparator Sourcing
      • Direct-to-Patient Services
      • Clinical Returns
      • Clinical Packaging
      • Project & Supply Management
    • Pharmaceutical Manufacturing
      • Commercial Manufacturing
      • over-the-counter-contract-manufacturing
      • Technology Transfers
      • High Potent API (HPAPI)
      • Scheduled Substances
      • Packaging
      • Regulatory Services
  • Dosage Forms
    • Oral Dosage
      • Oral Solid Dosage
      • Tablets
      • Capsules
      • Softgel
      • Oral Films
      • Oral Suspension & Solutions
      • Semi-Solids
      • Powders & Granules
    • Injectables / Parenterals
    • Topical
      • Semi Solids Dosage Forms
      • Transdermal Patches
      • Ophthalmic / Ocular
    • Transdermal
      • Semi Solids Dosage Forms
      • Transdermal Patches
    • Ophthalmic / Ocular
    • Inhalables / Nasal
    • Liquids
  • Formulation Technologies
    • Bioavailability Enhancement
    • Lipid Nanoparticles
      • Nanostructured Lipid Carriers
      • Liposomes
      • Solid Lipid Nanoparticles
      • Self-Emulsifying Drug Delivery Systems
      • Nanoemulsions
    • Lipid-Based Drug Delivery
    • Nanoparticles
      • Polymeric Nanoparticles
      • Nanocrystals
    • Amorphous Solid Dispersions
    • Controlled Release
    • Sustained Release
    • Microencapsulation
    • Multiparticulate
    • Taste Masking
    • Orally Disintegrating Tablets
    • Abuse Deterrent
  • Resources
    • Articles
    • Case Study
    • E-Book
    • Executive Summary
    • Offering Sheet
    • White Paper
  • About
    • Schedule a Meeting
    • Corporate Responsibility
    • Contact Us
Contact Us
Home » Development & Bioavailability

Development & Bioavailability

Menu
  • Services
    • Product Development
      • Formulation
        • Preformulation Studies
        • Formulation Development
      • Analytical
        • Analytical Method Development
        • Analytical Testing
        • Stability Testing
      • Polymorph Screening
      • IND Enabling Studies
      • GLP Toxicology Studies
      • Therapeutic Area
        • Orphan Disease / Rare Disease
        • Oncology
        • CNS / Neurology
        • Cardiometabolic Diseases
      • Pediatrics
    • Processing Technologies
      • Spray Drying
      • Wurster Fluid Bed Coating
      • Hot Melt Extrusion
      • Micronization & Milling
      • Particle Engineering
    • Clinical Trial Supply
      • Clinical Manufacturing
      • Solutions by Phase
        • Preclinical Manufacturing
        • Phase 1 Clinical Manufacturing
        • Phase 2 Clinical Manufacturing
        • Phase 3 Clinical Manufacturing
      • Comparator Sourcing
      • Direct-to-Patient Services
      • Clinical Returns
      • Clinical Packaging
      • Project & Supply Management
    • Pharmaceutical Manufacturing
      • Commercial Manufacturing
      • over-the-counter-contract-manufacturing
      • Technology Transfers
      • High Potent API (HPAPI)
      • Scheduled Substances
      • Packaging
      • Regulatory Services
  • Dosage Forms
    • Oral Dosage
      • Oral Solid Dosage
      • Tablets
      • Capsules
      • Softgel
      • Oral Films
      • Oral Suspension & Solutions
      • Semi-Solids
      • Powders & Granules
    • Injectables / Parenterals
    • Topical
      • Semi Solids Dosage Forms
      • Transdermal Patches
      • Ophthalmic / Ocular
    • Transdermal
      • Semi Solids Dosage Forms
      • Transdermal Patches
    • Ophthalmic / Ocular
    • Inhalables / Nasal
    • Liquids
  • Formulation Technologies
    • Bioavailability Enhancement
    • Lipid Nanoparticles
      • Nanostructured Lipid Carriers
      • Liposomes
      • Solid Lipid Nanoparticles
      • Self-Emulsifying Drug Delivery Systems
      • Nanoemulsions
    • Lipid-Based Drug Delivery
    • Nanoparticles
      • Polymeric Nanoparticles
      • Nanocrystals
    • Amorphous Solid Dispersions
    • Controlled Release
    • Sustained Release
    • Microencapsulation
    • Multiparticulate
    • Taste Masking
    • Orally Disintegrating Tablets
    • Abuse Deterrent
  • Resources
    • Articles
    • Case Study
    • E-Book
    • Executive Summary
    • Offering Sheet
    • White Paper
  • About
    • Schedule a Meeting
    • Corporate Responsibility
    • Contact Us
A scientist performing chemical experiment
Development & Bioavailability

What is Formulation Development? Why is it so important in making medicines?

Development & Bioavailability

When making medicines, figuring out how to turn a new drug into something people can take is a really big deal. This…

Read More What is Formulation Development? Why is it so important in making medicines?Continue

Two scientist experimenting in a pharma lab
Development & Bioavailability | Manufacturing | Oral Technology

Enteric-Protected Solid Oral Dosage Form Development 

Development & Bioavailability, Manufacturing, Oral Technology

Download Full Case Study Abstract: This comprehensive case study offers an exhaustive examination into the precise development of an enteric-protected solid oral…

Read More Enteric-Protected Solid Oral Dosage Form Development Continue

Image showing scientist performing chemical experiment
Development & Bioavailability | Manufacturing | Oral Technology

Development of a Multi-API (Multiparticulate) Fixed-Dose Combination Drug

Development & Bioavailability, Manufacturing, Oral Technology

Abstract: This case study provides a deep dive into Hycon’s achievement in developing a multi-API (Active Pharmaceutical Ingredient) fixed-dose combination oral drug,…

Read More Development of a Multi-API (Multiparticulate) Fixed-Dose Combination DrugContinue

Image showing medicine dosage
Development & Bioavailability

PBPK Modelling: Optimizing Controlled Release Dosage Form Development

Development & Bioavailability

Creating controlled release drugs, which release medicine at a specific rate or location in the digestive system, can be difficult. Physiologically-based pharmacokinetic…

Read More PBPK Modelling: Optimizing Controlled Release Dosage Form DevelopmentContinue

Image showing Tablet dissolving in water
Development & Bioavailability | Dosage Form Design | Oral Technology

How to Select an Optimal Formulation Strategy for Solubility

Development & Bioavailability, Dosage Form Design, Oral Technology

Why has solubility become a challenging aspect? The effectiveness of orally administered medicines hinges on the drug’s ability to dissolve in the gastrointestinal tract and promptly…

Read More How to Select an Optimal Formulation Strategy for SolubilityContinue

Image showing Hycon Tablets
Development & Bioavailability | Softgel Technology

Exploring Compatibility Between Lipid-Based Formulations and Shell Materials

Development & Bioavailability, Softgel Technology

To ensure the physical and chemical stability of Lipid-Based Formulations (LBFs), it is essential to find a delicate balance between the formulation…

Read More Exploring Compatibility Between Lipid-Based Formulations and Shell MaterialsContinue

Image showing a Lady showing a pill
Development & Bioavailability | Oral Technology | Softgel Technology

Softgel Technology’s Versatility: Encapsulating a Volatile Compound:

Development & Bioavailability, Oral Technology, Softgel Technology

Download

Read More Softgel Technology’s Versatility: Encapsulating a Volatile Compound:Continue

Image showing stethoscope and medicines
Development & Bioavailability | Dosage Form Design | Oral Technology

How to Accelerate Your Drug Product Development

Development & Bioavailability, Dosage Form Design, Oral Technology

DRUG DEVELOPMENT AND FORMULATION IS SCIENCE. DOSE DESIGN TO CREATE SUCCESSFUL TREATMENTS IS ART. Developing successful treatments that meet the needs of…

Read More How to Accelerate Your Drug Product DevelopmentContinue

Image showing scientist performing experiment
Development & Bioavailability

Strategies to Accelerate Your Molecule’s Development

Development & Bioavailability

INTRODUCTION The development of orally administered small molecules  is becoming more challenging as an increasing number  of molecules in pipelines have poor…

Read More Strategies to Accelerate Your Molecule’s DevelopmentContinue

A scientist experimenting in a pharma lab
Development & Bioavailability

The Role of Roller Compaction in Dose Design

Development & Bioavailability

Introduction:  Roller compaction is a popular dry granulation process with some significant advantages over wet granulation processes. It offers better overall stability…

Read More The Role of Roller Compaction in Dose DesignContinue

Page navigation

1 2 Next PageNext
Certified Organization Logo
Made in USA Logo
WHO - GMP Logo
Logo of Current Good Manufacturing Practice
Seal of the United States Drug Enforcement Administration
Image of ISO Certified Organization
FDA Approved Icon

Contact us today to start your project in 1 week!

Call +1 (631) 210-5235 to hit the ground running

Contact Us
HyCON Labs a premier small molecule CDMO, enabling pharmaceutical partners to slash development, and manufacturing costs and bring speed to market.
Youtube Linkedin
Services
  • Product Development
  • Processing Technologies
  • Clinical Trial Supply
  • Drug Product Manufacturing
  • Solutions by Phase
Explore
  • Dosage Forms
  • Formulation Technologies
  • Resources
  • About Us
  • Our Locations
Get In Touch

Phone No.: +1 631-210-5235

E-Mail ID: info@hyconlabs.com

© 2025 HyCON Labs Solutions. All Rights Reserved.